Symptoms
Common signs and symptoms of Hurthle Cell Carcinoma include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Hurthle Cell Carcinoma.
The exact mechanisms that trigger Hurthle cell carcinoma remain partially mysterious to researchers.
The exact mechanisms that trigger Hurthle cell carcinoma remain partially mysterious to researchers. What scientists do understand is that normal thyroid follicular cells undergo genetic mutations that cause them to accumulate unusually high numbers of mitochondria. These cellular powerhouses become enlarged and dysfunctional, creating the characteristic appearance of Hurthle cells. Over time, additional genetic changes can transform these altered cells into cancer.
Radiation exposure stands out as the most clearly established environmental cause.
Radiation exposure stands out as the most clearly established environmental cause. People who received radiation therapy to the head or neck area during childhood, or those exposed to nuclear accidents or atomic bomb testing, face significantly higher risks. The thyroid gland proves particularly vulnerable to radiation damage, especially during the growing years when the gland is most active.
Genetic factors also play a role, though inherited forms of Hurthle cell carcinoma are uncommon.
Genetic factors also play a role, though inherited forms of Hurthle cell carcinoma are uncommon. Some families show patterns of thyroid cancer across generations, suggesting that certain genetic variations may increase susceptibility. Chronic inflammation of the thyroid, particularly from autoimmune conditions like Hashimoto's thyroiditis, creates an environment where cellular changes are more likely to occur, though most people with thyroid inflammation never develop cancer.
Risk Factors
- Previous radiation exposure to the head or neck
- History of Hashimoto's thyroiditis or other thyroid diseases
- Female gender, especially during reproductive years
- Age between 40 and 60 years
- Family history of thyroid cancer
- Personal history of goiter or thyroid nodules
- Iodine deficiency in the diet
- Living in areas with volcanic soil
- Exposure to nuclear fallout or medical radiation
- Having other endocrine system cancers
Diagnosis
How healthcare professionals diagnose Hurthle Cell Carcinoma:
- 1
Diagnosing Hurthle cell carcinoma typically begins when a doctor feels a lump during a routine neck examination or when a patient notices changes in their neck.
Diagnosing Hurthle cell carcinoma typically begins when a doctor feels a lump during a routine neck examination or when a patient notices changes in their neck. The initial evaluation usually includes blood tests to check thyroid hormone levels and thyroid-stimulating hormone, though these are often normal even when cancer is present. An ultrasound of the thyroid provides the first detailed look at any nodules, showing their size, shape, and characteristics that might suggest malignancy.
- 2
When imaging reveals suspicious nodules, the next step involves a fine needle aspiration biopsy.
When imaging reveals suspicious nodules, the next step involves a fine needle aspiration biopsy. During this procedure, a thin needle extracts cells from the nodule for microscopic examination. However, Hurthle cell carcinoma presents a unique diagnostic challenge because the biopsy cannot reliably distinguish between benign Hurthle cell adenomas and malignant carcinomas. Both conditions show the same cellular appearance under the microscope, requiring surgical removal and comprehensive tissue examination to make the final diagnosis.
- 3
Additional imaging studies may include CT scans or MRI to evaluate the extent of disease, particularly if the cancer appears large or aggressive.
Additional imaging studies may include CT scans or MRI to evaluate the extent of disease, particularly if the cancer appears large or aggressive. A radioactive iodine scan is sometimes performed, though Hurthle cell carcinomas typically don't absorb iodine well, limiting the usefulness of this test. Genetic testing of tumor samples is increasingly used to help guide treatment decisions and assess prognosis. The definitive diagnosis ultimately depends on examining the entire removed tumor to look for invasion into surrounding tissues or blood vessels.
Complications
- The most immediate complications of Hurthle cell carcinoma relate to the cancer's tendency to spread locally and its resistance to traditional thyroid cancer treatments.
- Unlike papillary thyroid cancer, Hurthle cell carcinomas more frequently invade surrounding structures like the windpipe, swallowing tube, or voice box nerves.
- This local spread can cause persistent hoarseness, difficulty swallowing, or breathing problems that may require additional treatments beyond surgery.
- Recurrence represents another significant concern, occurring in roughly 15 to 30 percent of patients within the first decade after treatment.
- The cancer may return in the thyroid bed, nearby lymph nodes, or distant organs like the lungs or bones.
- Because these tumors typically don't respond well to radioactive iodine therapy, treatment options for recurrent disease can be more limited than with other thyroid cancers.
- However, surgical removal of recurrent disease is often possible, and newer targeted drug therapies are expanding treatment options for advanced cases.
- Long-term survival rates remain favorable when the cancer is detected early and treated appropriately, with many patients living normal lifespans after successful treatment.
Prevention
- Preventing Hurthle cell carcinoma focuses primarily on avoiding known risk factors, particularly radiation exposure.
- People should be cautious about unnecessary medical imaging that involves radiation, especially CT scans of the head and neck region.
- When radiation therapy is medically necessary, modern techniques can often minimize exposure to the thyroid gland.
- Parents should be particularly vigilant about radiation exposure in children, whose developing thyroid glands are most vulnerable to damage.
- Maintaining adequate iodine intake through diet or supplements may help reduce risk, particularly in areas where soil iodine levels are naturally low.
- Most people in developed countries get sufficient iodine from iodized salt and dairy products, but those following very restrictive diets should discuss iodine supplementation with their healthcare providers.
- Regular medical checkups that include neck examinations can help detect thyroid problems early, when treatment is most successful.
- While genetic factors cannot be changed, people with family histories of thyroid cancer should discuss increased screening with their doctors.
- Some may benefit from more frequent thyroid examinations or earlier intervention for suspicious nodules.
- Managing autoimmune thyroid conditions like Hashimoto's thyroiditis with appropriate medical care may also help reduce long-term cancer risk, though the relationship between inflammation and cancer development remains complex.
Surgery remains the primary and most effective treatment for Hurthle cell carcinoma.
Surgery remains the primary and most effective treatment for Hurthle cell carcinoma. Most patients require complete removal of the thyroid gland, called total thyroidectomy, because these cancers tend to be more aggressive than other thyroid malignancies. The surgical approach may also include removing nearby lymph nodes if they appear enlarged or if the cancer has spread. Experienced thyroid surgeons typically achieve excellent outcomes, though the procedure requires careful attention to preserve the parathyroid glands and voice box nerves.
Unlike many other thyroid cancers, Hurthle cell carcinomas rarely respond to radioactive iodine therapy.
Unlike many other thyroid cancers, Hurthle cell carcinomas rarely respond to radioactive iodine therapy. This resistance occurs because Hurthle cells don't effectively absorb iodine, making this traditional treatment largely ineffective. However, some doctors may still attempt radioactive iodine treatment in cases where the cancer shows some iodine uptake or has spread to lymph nodes. External beam radiation therapy may be recommended for older patients or those with locally advanced disease that cannot be completely removed surgically.
Following surgery, patients require lifelong thyroid hormone replacement therapy with levothyroxine.
Following surgery, patients require lifelong thyroid hormone replacement therapy with levothyroxine. This medication serves two purposes: replacing the hormones normally produced by the thyroid and suppressing the release of thyroid-stimulating hormone, which could potentially encourage any remaining cancer cells to grow. The dosage is carefully adjusted to maintain hormone levels in the optimal range while avoiding side effects from too much thyroid hormone.
For advanced or metastatic Hurthle cell carcinoma, newer targeted therapies show promise.
For advanced or metastatic Hurthle cell carcinoma, newer targeted therapies show promise. Drugs like lenvatinib and sorafenib, originally developed for other cancers, have demonstrated effectiveness in treating advanced thyroid cancers that don't respond to conventional treatments. Clinical trials continue to explore additional targeted therapies and immunotherapy approaches, offering hope for patients with difficult-to-treat cases. Regular monitoring with blood tests, imaging studies, and physical examinations helps detect any recurrence early when treatment is most effective.
Living With Hurthle Cell Carcinoma
Living with Hurthle cell carcinoma requires establishing a new routine centered around regular medical monitoring and daily hormone replacement therapy. Most patients take levothyroxine every morning on an empty stomach, waiting at least 30 to 60 minutes before eating or drinking coffee. Getting into this routine becomes second nature for most people, though remembering to take the medication consistently is crucial for maintaining energy levels and overall health.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Mar 31, 2026v1.0.0
- Published by DiseaseDirectory